{"id":"W2762323160","doi":"10.1016/s1470-2045(17)30605-8","title":"Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre","funders":"","keywords":"Cabazitaxel; Docetaxel; Medicine; Prostate cancer; Enzalutamide; Mitoxantrone; Prednisone; Oncology; Internal medicine; Chemotherapy; Cancer; Urology; Androgen deprivation therapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001230976,0.00181647,0.002278435,0.0004546711,0.000385681,0.001424392,0.001078082,0.001453972,0.00793036],"category_scores_gemma":[0.001018931,0.0006922593,0.001925267,0.0005134157,0.001376937,0.001306288,0.0004391546,0.004040842,0.001104228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001185954,"about_ca_system_score_gemma":0.001196181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002888637,"about_ca_topic_score_gemma":0.008676261,"domain_scores_codex":[0.9996312,0.0001627514,0.00001461082,0.00007615482,0.00002604539,0.00008916741],"domain_scores_gemma":[0.9994229,0.0001333107,0.0001167699,0.0000321878,0.00002464956,0.0002701717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9674328,0.004951689,0.0006529224,0.0006995145,0.001213224,0.00004623175,0.00009743361,0.0007102958,0.002874846,0.0002208814,0.001823374,0.01927668],"study_design_scores_gemma":[0.9295324,0.06598884,0.002127255,0.00004028555,0.0004991734,0.00005899688,0.00005286334,0.0004111316,0.0003008986,0.0001916387,0.0007748234,0.00002167195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880005,0.005150733,0.0003213628,0.0009263475,0.0004744391,0.00113076,0.00098477,0.0001741532,0.002836895],"genre_scores_gemma":[0.9876748,0.003106846,0.0007685224,0.0008700249,0.0002813817,0.0007963828,0.001431905,0.00003731177,0.005032699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00793036,"threshold_uncertainty_score":0.02652973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0842271304700907,"score_gpt":0.3939221756151177,"score_spread":0.309695045145027,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}